PUBLISHER: The Insight Partners | PRODUCT CODE: 1562226
PUBLISHER: The Insight Partners | PRODUCT CODE: 1562226
The South & Central America fill finish manufacturing market was valued at US$ 403.07 million in 2022 and is expected to reach US$ 731.41 million by 2030; it is estimated to grow at a CAGR of 7.7% from 2022 to 2030.
Significant Pipeline for Biologics Fuels South & Central America Fill Finish Manufacturing Market
Aseptic processing will need coordination, risk management, and regulatory compliance as the fill-finish industry grows quickly. In biologics, fill-finish manufacturing is essential to maintaining product integrity, sterility, and regulatory compliance. The potential for biosimilars to reduce biologic medicine costs and improve patient access to care. Biosimilars will open new avenues for innovation and scientific advancement. Therefore, a sizable biologics pipeline raises the need for fill-finish manufacturing and possibly creates opportunities. In terms of authorized follow-up biological drugs, Brazil ranks fourth globally. As of May 2023, the Brazilian Health Regulatory Agency, ANVISA (Agencia Nacional de Vigilancia Sanitaria), has approved 52 follow-on biological medications and about 30 biological products that are either undergoing testing or have already undergone testing.
South & Central America Fill Finish Manufacturing Market Overview
Brazil is the fifth largest country globally by area and population and is experiencing the fastest demographic aging as well as huge cases of noncommunicable diseases (NCD), which is expected to offer massive growth opportunities for the market growth in the coming years. For instance, per the World Health Organization, in 2023, NCDs are estimated to account for 74% of all deaths. To accommodate higher demand projections and increased volume, a new greenfield aseptic fill/finish site was designed due to regulatory pressures on the current facility. In addition, the project instituted advanced aseptic processing in Brazil. Therefore, the rise in strategic initiatives is expected to fuel the market for fill finish manufacturing in the country during the forecast period.
South & Central America Fill Finish Manufacturing Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Fill Finish Manufacturing Market Segmentation
The South & Central America fill finish manufacturing market is segmented based on product, modality, end user, and country. Based on product, the South & Central America fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held a larger market share in 2022. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.
In terms of modality, the South & Central America fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held the largest market share in 2022.
By end user, the South & Central America fill finish manufacturing market is segmented into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held the largest market share in 2022.
Based on country, the South & Central America fill finish manufacturing market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America fill finish manufacturing market share in 2022.
Becton Dickinson and Co, Gerresheimer AG, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Europe NV, Optima Packaging Group Gmbh, Schott AG, SGD SA, Stevanato Group SpA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc are some of the leading players operating in the South & Central America fill finish manufacturing market.